Literature DB >> 27698888

miRNA regulation of Sirtuin-1 expression in human astrocytoma.

Sara Giovanna Romeo1, Alfredo Conti1, Francesca Polito1, Chiara Tomasello1, Valeria Barresi2, Domenico La La Torre1, Maria Cucinotta1, Flavio Filippo Angileri1, Marcello Bartolotta2, Rosa Maria Di Giorgio1, M'Hammed Aguennouz1.   

Abstract

Sirtuins are a family of 7 histone deacetylases largely involved in the regulation of cell proliferation, survival and death. The role of sirtuins in tumorigenesis and cancer progression has been previously studied in certain cancer types. Few studies have investigated sirtuin expression in gliomas, with controversial results. The aim of the present study was to investigate the expression of sirtuin-1 (Sirt-1) in diffuse astrocytoma [low grade astrocytoma (LGA)], anaplastic astrocytoma (AA) and glioblastoma multiforme (GBM) and in primary glioma cell lines: PLGAC (primary LGA cells); PAAC (primary AA cells); and PGBMC (primary GBM cells). Tumor samples were obtained from patients who underwent craniotomy for microsurgical tumor resection at the Neurosurgery Unit of the University of Messina between 2011 and 2014. Sirt-1 expression was qualitatively analyzed in 30 human glial tumor samples and 5 non-neoplastic brain tissue (NBT) specimens using immunohistochemistry and western blotting techniques. Sirt-1 expression was quantitatively analyzed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). In addition, Sirt-1 expression in primary cell lines was investigated by immunoblotting and RT-qPCR. Sirt-1 expression was downregulated in gliomas compared to NBTs. Sirt-1 levels also varied among different tumor grades, with more evident downregulation in high-grade (P<0.001) than low-grade tumors (P<0.01). These data were confirmed in cell lines, with the exception of upregulation of protein level in the highest malignancy grade cell lines. The present results suggest a role for miRNA-34a, miRNA-132 and miRNA-217 in the epigenetic control of Sirt-1 during gliomagenesis and progression, and demonstrate the different implications of Sirt-1 in human tissues and cell lines. Furthermore, the present results reveal that Sirt-1 may be an intrinsic regulator of tumor progression and the regulation of Sirt-1 involves complex molecular pathways. However, the biological functions of Sirt-1 in gliomagenesis require additional investigation.

Entities:  

Keywords:  Sirtuin-1; astrocytoma; glioblastoma multiforme; glioma cell lines; histone deacethylases

Year:  2016        PMID: 27698888      PMCID: PMC5038465          DOI: 10.3892/ol.2016.4960

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  62 in total

1.  Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

Authors:  Shuyu Zhang; Jun Hao; Fang Xie; Xiangui Hu; Cong Liu; Jian Tong; Jundong Zhou; Jinchang Wu; Chenghao Shao
Journal:  Carcinogenesis       Date:  2011-06-10       Impact factor: 4.944

2.  SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1.

Authors:  Toula Bouras; Maofu Fu; Anthony A Sauve; Fang Wang; Andrew A Quong; Neil D Perkins; Ronald T Hay; Wei Gu; Richard G Pestell
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

3.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

Review 4.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

5.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

6.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

Review 7.  Sirtuins in mammals: insights into their biological function.

Authors:  Shaday Michan; David Sinclair
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

Review 8.  Sirtuins: critical regulators at the crossroads between cancer and aging.

Authors:  L R Saunders; E Verdin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

9.  Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation.

Authors:  Kevin Pruitt; Rebekah L Zinn; Joyce E Ohm; Kelly M McGarvey; Sung-Hae L Kang; D Neil Watkins; James G Herman; Stephen B Baylin
Journal:  PLoS Genet       Date:  2006-03-31       Impact factor: 5.917

Review 10.  SIRT1, is it a tumor promoter or tumor suppressor?

Authors:  Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2009-01-21       Impact factor: 6.580

View more
  5 in total

Review 1.  Advances in epigenetic glioblastoma therapy.

Authors:  Dong Hoon Lee; Hyun-Wook Ryu; Hye-Rim Won; So Hee Kwon
Journal:  Oncotarget       Date:  2017-03-14

2.  Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth in vitro and in vivo partially through acetylation of p53.

Authors:  Batsaikhan Buyandelger; Eli E Bar; Kuo-Sheng Hung; Ruei-Ming Chen; Yung-Hsiao Chiang; Jing-Ping Liou; Huei-Mei Huang; Jia-Yi Wang
Journal:  Int J Biol Sci       Date:  2020-10-19       Impact factor: 6.580

3.  MiR-140-3p inhibits the cell viability and promotes apoptosis of synovial fibroblasts in rheumatoid arthritis through targeting sirtuin 3.

Authors:  Beibei Zu; Lin Liu; Jingya Wang; Meirong Li; Junxia Yang
Journal:  J Orthop Surg Res       Date:  2021-02-02       Impact factor: 2.359

4.  Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma.

Authors:  Caleb J Yelton; Swapan K Ray
Journal:  Neuroimmunol Neuroinflamm       Date:  2018-11-12

5.  Noninvasive quantification of SIRT1 expression-activity and pharmacologic inhibition in a rat model of intracerebral glioma using 2-[18F]BzAHA PET/CT/MRI.

Authors:  Maxwell T Laws; Robin E Bonomi; David J Gelovani; Jeremy Llaniguez; Xin Lu; Thomas Mangner; Juri G Gelovani
Journal:  Neurooncol Adv       Date:  2020-01-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.